GlaxoSmithKline Pharmaceuticals Key Metrics
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Sector: Biotechnology & Drugs| Return on average equity - 5 year average | 35.40 |
| Net Income/employee - trailing 12 month | 34,42,322.00 |
| Revenue/employee - most recent fiscal year | 1,22,96,250.00 |
| Return on investment - most recent fiscal year | 43.64 |
| Return on average assets - most recent fiscal year | 24.57 |
| Receivables turnover - most recent fiscal year | 12.99 |
| Return on investment - trailing 12 month | 0.00 |
| Return on average assets - trailing 12 month | 0.00 |
| Inventory turnover - most recent fiscal year | 3.05 |
| Inventory turnover - trailing 12 month | 0.00 |
| Revenue/employee - trailing 12 month | 1,27,45,550.00 |
| Return on average assets - 5 year average | 18.31 |
| Net Income/employee - most recent fiscal year | 33,33,277.00 |
| Return on average equity - trailing 12 month | 0.00 |
| Receivables turnover - trailing 12 month | 0.00 |
| Asset turnover - most recent fiscal year | 0.91 |
| Asset turnover - trailing 12 month | 0.00 |
| Return on average equity - most recent fiscal year | 49.11 |
| Return on investment - 5 year average | 31.28 |
GlaxoSmithKline Pharmaceuticals Quick Links
GlaxoSmithKline Pharmaceuticals Dividend GlaxoSmithKline Pharmaceuticals Bonus GlaxoSmithKline Pharmaceuticals News GlaxoSmithKline Pharmaceuticals AGM GlaxoSmithKline Pharmaceuticals Rights GlaxoSmithKline Pharmaceuticals Splits GlaxoSmithKline Pharmaceuticals Board Meetings GlaxoSmithKline Pharmaceuticals Shareholdings GlaxoSmithKline Pharmaceuticals Profit Loss GlaxoSmithKline Pharmaceuticals Balance Sheet GlaxoSmithKline Pharmaceuticals Cashflow GlaxoSmithKline Pharmaceuticals Q1 Results GlaxoSmithKline Pharmaceuticals Q2 Results GlaxoSmithKline Pharmaceuticals Q3 Results GlaxoSmithKline Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.